$1.16
Insights on Tc Biopharm Ltd
In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 151.3%
2.59%
Downside
Day's Volatility :5.83%
Upside
3.33%
26.72%
Downside
52 Weeks Volatility :99.57%
Upside
99.42%
Period | Tc Biopharm Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -4.92% | 0.0% |
6 Months | -88.4% | 0.0% |
1 Year | -92.85% | 0.0% |
3 Years | -99.95% | -20.1% |
Market Capitalization | 5.4M |
Book Value | $1.05 |
Earnings Per Share (EPS) | -19.31 |
Wall Street Target Price | 140.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -108.92% |
Return On Equity TTM | -556.68% |
Revenue TTM | 2.9M |
Revenue Per Share TTM | 29.64 |
Quarterly Revenue Growth YOY | 188.6% |
Gross Profit TTM | 3.8M |
EBITDA | -12.9M |
Diluted Eps TTM | -19.31 |
Quarterly Earnings Growth YOY | -0.87 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 11968.97%
Sell
Neutral
Buy
Tc Biopharm Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Tc Biopharm Ltd | -26.58% | -88.4% | -92.85% | -99.95% | -99.95% |
Moderna, Inc. | 37.56% | 83.82% | 13.37% | -12.47% | 553.14% |
Regeneron Pharmaceuticals, Inc. | 10.42% | 24.29% | 32.26% | 98.6% | 210.52% |
Novo Nordisk A/s | 7.9% | 30.89% | 58.53% | 230.87% | 458.51% |
Vertex Pharmaceuticals Incorporated | 10.52% | 25.13% | 30.01% | 109.26% | 156.43% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Tc Biopharm Ltd | NA | NA | NA | 0.0 | -5.57 | -1.09 | NA | 1.05 |
Moderna, Inc. | 24.73 | NA | 0.0 | -6.46 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 29.16 | 29.16 | 1.46 | 44.2 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 45.83 | 45.83 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 28.9 | 28.9 | 0.53 | 17.11 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Tc Biopharm Ltd | Buy | $5.4M | -99.95% | NA | 0.0% |
Moderna, Inc. | Buy | $54.0B | 553.14% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.8B | 210.52% | 29.16 | 29.45% |
Novo Nordisk A/s | Buy | $592.1B | 458.51% | 45.83 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $115.1B | 156.43% | 28.9 | 39.46% |
Armistice Capital, LLC
Tower Research Capital LLC
Citadel Advisors Llc
Organization | Tc Biopharm Ltd |
Employees | 41 |
CEO | Mr. Bryan L. Kobel |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$1.16
+0.0%
Keyarch Acquisition Corp
$1.16
+0.0%
Connexa Sports Technologies Inc
$1.16
+0.0%
Us Value Etf
$1.16
+0.0%
First Wave Biopharma Inc
$1.16
+0.0%
Global X Msci Next Emerging
$1.16
+0.0%
Fat Projects Acquisition Corp
$1.16
+0.0%
Ishares Intl Div Growth Etf
$1.16
+0.0%
Corsair Gaming, Inc.
$1.16
+0.0%